Cargando…
Evaluation of 25% Poloxamer As a Slow Release Carrier for Morphine in a Rat Model
The objectives of this study were to evaluate poloxamer as a slow release carrier for morphine (M) and potential tissue irritation after subcutaneous poloxamer–morphine (PM) injection in a rat model. Based on the result of a previous in vitro work, 25% poloxamer, with and without morphine, and salin...
Autores principales: | Sulimai, Nurul H., Ko, Jeff C., Jones-Hall, Yava L., Weng, Hsin-Yi, Deng, Meng, Breur, Gert J., Knipp, Gregory T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854640/ https://www.ncbi.nlm.nih.gov/pubmed/29594153 http://dx.doi.org/10.3389/fvets.2018.00019 |
Ejemplares similares
-
Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected?
por: Bertin, Célian, et al.
Publicado: (2023) -
Case report: Use of penicillin G potassium in poloxamer 407 gel to aid in healing of an equine sublingual abscess
por: Larsen, Elizabeth A., et al.
Publicado: (2022) -
Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets
por: McLean, Stuart, et al.
Publicado: (2009) -
Mechanical, Rheological and Release Behaviors of a Poloxamer 407/Poloxamer 188/Carbopol 940 Thermosensitive Composite Hydrogel
por: Chen, Jianping, et al.
Publicado: (2013) -
Use of Slow-Release Injectable Moxidectin for Treatment of Dirofilaria immitis Infection During Pregnancy
por: Alberigi, Bruno, et al.
Publicado: (2020)